CJ Corp
KRX:001040
CJ Corp
Note Receivable
CJ Corp
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
CJ Corp
KRX:001040
|
Note Receivable
₩429.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
SK Inc
KRX:034730
|
Note Receivable
₩1.9T
|
CAGR 3-Years
16%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Doosan Corp
KRX:000150
|
Note Receivable
₩151.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-14%
|
|
|
Samsung C&T Corp
KRX:028260
|
Note Receivable
₩772.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
0%
|
|
|
LG Corp
KRX:003550
|
Note Receivable
₩18.2B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-2%
|
|
|
Hanwha Corp
KRX:000880
|
Note Receivable
₩1.2T
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-25%
|
|
CJ Corp
Glance View
CJ Corp, a conglomerate based in South Korea, has successfully woven itself into the fabric of everyday life across diverse sectors, ranging from food and pharmaceuticals to entertainment and logistics. Originally part of the Samsung Group until its spin-off in the 1990s, CJ Corp has leveraged its strategic vision to become a pivotal player in the global market. Its food division, for instance, is recognized for manufacturing and distributing a wide array of products, including the globally popular Bibigo brand, which offers items such as ready-to-eat meals and condiments. By capitalizing on health trends and consumer convenience, CJ's food division has managed to secure a significant market share both domestically and internationally. The company's influence extends beyond the culinary sphere into the realm of culture and technology. CJ Entertainment & Media spearheads this effort, producing blockbuster films and K-dramas that capture global audiences, as seen with the international success of films like "Parasite." Furthermore, the conglomerate’s logistics arm, CJ Logistics, operates with cutting-edge technology to streamline supply chains and distribution networks, thereby providing comprehensive management solutions. Meanwhile, CJ's biotechnology and healthcare ventures underscore its commitment to innovation, where scientific advances enhance its pharmaceutical offerings. Collectively, these diverse yet interlinked strategies enable CJ Corp to generate substantial revenue streams while maintaining a strong presence across multiple platforms, driving their continued growth and influence.
See Also
What is CJ Corp's Note Receivable?
Note Receivable
429.8B
KRW
Based on the financial report for Sep 30, 2025, CJ Corp's Note Receivable amounts to 429.8B KRW.
What is CJ Corp's Note Receivable growth rate?
Note Receivable CAGR 5Y
19%
Over the last year, the Note Receivable growth was 9%. The average annual Note Receivable growth rates for CJ Corp have been 4% over the past three years , 19% over the past five years .